BI-78-D3

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameBI-78-D3
Drug Alias NameBI-78D3BI-78-D-3BI-78-D3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionc-Jun N-terminal kinase inhibitors
Targetsc-Jun N-terminal kinase
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBurnham Institute for Medical Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBurnham Institute for Medical Research
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A